Annona muricata Leaf as an Anti-Cryptosporidial Agent: An In Silico Molecular Docking Analysis and In Vivo Studies

Bibliographic Information
Authors: El-Wakil E.S.; Abdelmaksoud H.F.; Wakid M.H.; Alsulami M.N.; Hammam O.; Albohiri H.H.; Ghallab M.M.I.
Journal: Pharmaceuticals
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
Publication Date: 14 June 2023
Volume / Issue: Volume 16 / Issue 6
Article No.: 878
ISSN: 14248247
DOI: 10.3390/ph16060878
Scopus: View on Scopus
Document Type: Article
Access: All Open Access; Gold Open Access; Green Open Access
Authors and Affiliations
El-Wakil E.S., Department of Parasitology, Theodor Bilharz Research Institute, Imbaba, 12411, Egypt; Abdelmaksoud H.F., Department of Parasitology, Theodor Bilharz Research Institute, Imbaba, 12411, Egypt; Wakid M.H., Department of Medical Laboratory Sciences, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, 21589, Saudi Arabia, Special Infectious Agents Unit, King Fahd Medical Research Center, King Abdulaziz University, Jeddah, 21589, Saudi Arabia; Alsulami M.N., Department of Biology, College of Science, University of Jeddah, Jeddah, 21589, Saudi Arabia; Hammam O., Department of Pathology, Theodor Bilharz Research Institute, Imbaba, 12411, Egypt; Albohiri H.H., Department of Biology, College of Science, University of Jeddah, Jeddah, 21589, Saudi Arabia; Ghallab M.M.I., Department of Medical Parasitology, Faculty of Medicine, Kafrelsheikh University, Kafrelsheikh, 33516, Egypt
Abstract
Cryptosporidiosis is a serious parasitic diarrheal disease linked to the occurrence of colorectal cancer in immunocompromised patients. The FDA-approved drug nitazoxanide (NTZ) achieved a temporary effect, and relapses occur. Annona muricata leaf is widely used in traditional medicine to treat a wide range of disorders, including antiparasitic and anticancer effects. So, this study aimed to investigate Annona muricata leaf antiparasitic and anticancer properties compared to NTZ in Cryptosporidium parvum (C. parvum) acutely and chronically infected immunosuppressed mice. A molecular docking analysis was performed to evaluate the effectiveness of some biologically active compounds that represented the pharmacological properties of Annona muricata leaf-rich extract toward C. parvum lactate dehydrogenase compared to NTZ. For the in vivo study, eighty immunosuppressed albino mice were classified into four groups as follows: group I: infected and treated with A. muricata; group II: infected and treated with nitazoxanide; group III: infected and received no treatment; and group IV: were neither infected nor treated. Furthermore, half of the mice in groups I and II received the drugs on the 10th day post-infection (dpi), and the other half received treatment on the 90th day post-infection. Parasitological, histopathological, and immunohistochemical evaluations were performed. The docking analysis showed that the lowest estimated free energy of binding of annonacin, casuarine, L-epigallocatechin, P-coumaric acid, and ellagic acid toward C. parvum LDH, were −6.11, −6.32, −7.51, −7.81, and −9.64 kcal/mol, respectively, while NTZ was −7.03 kcal/mol. Parasitological examination displayed a significantly high difference in C. parvum oocyst mean counts in groups I and II compared to group III (p-value < 0.001), with group I demonstrating the highest efficacy. The analyses of histopathological and immunohistochemical results revealed that group I showed restoration of the normal villous pattern without evidence of dysplasia or malignancy. A. muricata leaf has proved to be a reliable agent for Cryptosporidium treatment. This paper argues for its promising use as an antiparasitic agent and for the prevention of neoplastic sequels of Cryptosporidium infection. © 2023 by the authors.
Keywords
Annona muricata; Cryptosporidium; immunocompromised mice; nitazoxanide immunohistochemistry; Annona muricata extract; annonacin; casuarine; ellagic acid; lactate dehydrogenase; levo epigallocatechin; nitazoxanide; para coumaric acid; plant medicinal product; unclassified drug; albino mouse; animal experiment; animal model; animal tissue; anticryptosporidial agent; antineoplastic activity; antiparasitic activity; Article; binding affinity; chronic infection; comparative effectiveness; computer model; controlled study; cryptosporidiosis; Cryptosporidium parvum; drug structure; histopathology; immunohistochemistry; in vivo study; infection prevention; molecular docking; mouse; nonhuman; parasite examination; plant leaf
Citation Information
Scopus Citations: 14
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
